Cargando…
COVID-19 prevalence and outcomes in patients receiving biologic therapies at an infusion center in New York City
To better understand COVID-19 infection in patients receiving biologic and immunomodulatory therapies, we evaluated prevalence and outcomes for symptomatic cases of COVID-19 at a large therapeutic infusion center in New York City during the height of the pandemic. 2074 patients received treatment wi...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294696/ https://www.ncbi.nlm.nih.gov/pubmed/34302970 http://dx.doi.org/10.1016/j.clim.2021.108803 |